Trials / Sponsors / Immodulon Therapeutics Ltd
Immodulon Therapeutics Ltd
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma Melanoma | Phase 2 | 2018-10-04 |
| Terminated | Study of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable Cancer Metastatic Cancer | Phase 1 / Phase 2 | 2017-05-31 |
| Completed | A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2012-05-30 |
| Terminated | A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001 Malignant Melanoma | Phase 1 / Phase 2 | 2012-02-01 |
| Completed | A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 2 | 2011-06-01 |
| Completed | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Pati Melanoma | Phase 1 | 2010-03-01 |